Prevalence, Disease-free, and Overall Survival of Contemporary Patients With Renal Cell Carcinoma Eligible for Adjuvant Checkpoint Inhibitor Trials
Lorenzo Marconi, Maxine Sun, Christian Beisland, Tobias Klatte, Börje Ljungberg, Grant D. Stewart, Saeed Dabestani, Toni K. Choueiri, Axel Bex
Topics & Concepts
MedicineRenal cell carcinomaOncologyInternal medicineAdjuvantDiseaseClinical trialCarcinomaRenal cell carcinoma treatmentFerroptosis and cancer prognosisBladder and Urothelial Cancer Treatments